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CORTICOSTEROIDS, in spite of their well-known side 
effects, have essentially always been an integral part 
of immunosuppressive regimens in renal transplantation. 
With the introduction of tacrolimus, however, steroid with-
drawal has been possible in some 70% of successfully 
transplanted adults and children. 1-8 An important question, 
however, concerns the outcome after steroid withdrawal in 
adult patients on tacrolimus. We looked at our adult renal 
transplant patients receiving tacrolimus-based immunosup-
pression' and examined the short- and medium-term out-
comes after steroid withdrawal. 
PATIENT AND METHODS 
Between August 1991 and December 1996, 795 renal transplants 
were ')Jerformed in adult patients receiving tacrolimus-based im-
munosuppression at the University of Pittsburgh. 43 (5%) of these 
grafts were lost within 3 weeks of transplantation, and the recipi-
ents were still on steroids at the time of graft loss, and 4 were lost 
to follow-up; both groups were excluded from further analysis. The 
mean recipient age was 46:':: 14 years (range 18-84). Five hundred 
fifty-four (74%) were primary transplants, and 194 (26%) were 
second (n = 144), third (n = 39), or fourth (n = 11) transplants. 
Four hundred forty-two (59%) were males anef 306 (41 %) were 
females. Six hundred three (81%) were whites, 116 (15%) were 
African-Americans, and 29 (4%) were Asians. The mean PRA was 
11 :':: 22.5% (range 0 to 100). 
The mean donor age was 36 :':: 19 years (range 0.1 to 77). Six 
hundred fifty-six (88%) kidneys were from cadaveric donors. The 
mean cold ischemia time was 30.7 :': 9.5 hours. There were 92 
(12%) living donors. The mean number of HLA matches and 
mismatches was 2.7 :': 1.4 and 2.9 :': 1.5, respectively. The mean 
number of DR·matches and mismatches was 1.1 :': 0.6 and 0.8 :': 
0.7, respectively. 
Immunosuppression was with tacrolimus and steroids with or 
without azathioprine, mycophenolate mofetil, or a one week course 
of low·dose cyclophosphsmide, as previously described.'-3 Indue· 
tion antilymphocyte antibodies were generally not used. Although 
there were no formal a priori inclusion or exclusion criteria for 
complete withdrawal, steroids were tapered and discontinued in 
patients who maintained stable allograft function as the steroid 
dosage was gradually decreased. Steroids were restarted in recipi-
ents who experienced a rising serum creatinine with biopsy-proven 
acute rejection. Allograft failure was defined by return to dialysis, 
retransplantation, or death. 
Patient survival was calculated from the date of kidney trans-
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plantation until death, and graft survival was calculated from the 
date of kidney transplantation until graft failure or patient death. 
SUIvival curves were generated using the Kaplan-Meier (Product 
limit) method and were compared using the log-rank test. Values 
are presented as mean :': SD. A time dependent Cox regression 
analysis for hazard assumption was done to compare graft survival 
in recipients who came off steroids versus those who never came 
off. A Cox time dependent covariate z (t) was modeled, so that z 
(t) = 1 if the patient was weaned off at least once, and z (t) = 0 if 
the patient was not weaned off by time t. 
A multivariate multiple logistic regression analysis was per-
formed to compare the effect of recipient sex, recipient race, 
delayed graft function, recipient PRA, total HLA-matches, total-
HLA mismatches, donor age, and donor type (cadaveric vs living 
related) on steroid withdrawal. The means between groups were 
compared by one way analysis of variance (ANOVA). Catagorical 
data were analyzed by Pearson chi-square method. P values less 
than 0.05 were considered statistically significant. 
RESULTS 
Five hundred thirty-one (71 %) patients were taken off 
prednisone a median of 9.7 months after transplantation. 
Of these 5J1 patients, 398 (75%) remained off prednisone 
(OFF), and 133 (25%) were restarted on prednisone a 
median of 14.5 months after discontinuing steroids (OFF/ 
ON). Two hundred seventeen (29%) were never taken off 
prednisone (ON). The mean follow-up was 4.6 ::!:: 2.6 years. 
The 1, 3, and 5 year actuarial patient survivi.d rates in the 
OFF group were 99.7%, 98%, and 96%, respectively; in the 
OFF/ON group, they were 99%, 98%, and 93%. (P = NS 
compared to the OFF group), and in the ON group, they 
were 91 %, 82%, and 78% (P = .0001 compared to the OFF 
and OFF/ON groups). The 1, 3, and 5 year actuarial graft 
survival rates in the OFF group were 99.5%, 96%, and 89% 
respectively; in the OFF/ON group, they were 98.5%, 89%, 
and 71 %, and in the ON-group, they were 74%, 52%, and 
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42% (P = .0001). A Cox regression analysis showed that the 
hazard assumption for graft failure for those who came off 
prednisone was 0.124 relative to those who were never off 
prednisone (P < .0001). Acute rejection-free survival was 
65% in the OFF group compared to 20%, and 24% in the 
OFF/ON and ON groups respectively (P < .05). The 
incidences of steroid resistant rejection episodes were 4% 
in the OFF group, and 12%, and 22% in the OFF/ON, and 
ON groups respectively (P < .001). There were 82 (21 %) 
retransplants in the OFF group, 33 (25%) in the OFF/ON 
group, and 66 (30%) in the ON group (P < .001). The mean 
PRA was higherjn the ON group 14.9 ::!:: 26%, than in the 
OFF group, 9.4 ::!:: 20.6%, and the OFF/ON group, 10.2 ::!:: 
20.4% (P = .01). There was no effect of donor race and sex, 
recipient race and sex, cadaveric vs living donor, 48-hour 
graft function, and total HLA mismatches or matches on 
the likelihood of being weaned off steroids. In the OFF 
group, the serum creatinine at most recent follow-up was 
1.8 ::!:: 1.7 mgldL; in the OFF/ON and ON groups, it was 
3.7 ::!:: 2.9 mgldL and 4.5 ::!:: 3.8 mgldL, respectively (P = 
.0001). In the OFF group, the hematocrit at most recent 
follow-up was 40 ::!:: 7.2; whereas, in the OFF/ON and ON 
groups, it was 35 ::!:: 7.3, and 33 ::!:: 7.9 respectively (P = .01). 
The mean tacrolimus level in the OFF group was 8.2 ::!:: 3.9 
nglmL at last follow-up; in the OFF/ON and ON groups it 
was 8.3 ::!:: 4.1 nglmL, and 10.5 ::!:: 6.6 nglmL, respectively 
(P = .03). 
DISCUSSION 
The primary goal of this analysis was to assess the safety of 
steroid withdrawal in our adult renal transplant recipients 
receiving tacrolimus-based immunosuppression. The main 
questions for us concerned the safety of steroid withdrawal 
and, more importantly, the outcomes in patients who were 
withdrawn from and then resumed steroids. It should be 
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emphasized that patients were not randomly assigned to 
steroid withdrawal, and patients who never came off (ON), 
and those who were withdrawn from and then resumed 
steroids (OFF/ON), had a number of risk factors, including 
retransplantation, sensitization, and acute rejection. Five 
year patient survival rates were essentially the same in the 
OFF and the OFF/ON groups, but 5-year graft survival 
rates were significantly lower in the OFF/ON group com-
pared to the OFF group. The incidence of rejection and the 
mean serum creatinine were higher in the OFF/ON group, 
and these findings are of concern with regard to long term 
follow-up. 
To summarize, these data suggest that steroid withdrawal 
in adult renal transplant patients receiving tacrolimus-based 
immunosuppression is associated with reasonable medium-
term patient and graft survival and reasonable graft func-
tion. The patients who discontinued and then resumed 
steroids had comparable patient survival, but lower graft 
survival and worse renal function. The patients who never 
discontinued prednisone had the worst outcome. 
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